SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017533
Filing Date
2020-08-11
Accepted
2020-08-11 17:05:39
Documents
41
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gnpx20200630_10q.htm 10-Q 540307
2 EXHIBIT 31.1 ex_191888.htm EX-31.1 17812
3 EXHIBIT 31.2 ex_191889.htm EX-31.2 14570
4 EXHIBIT 32.1 ex_191890.htm EX-32.1 9702
  Complete submission text file 0001437749-20-017533.txt   3155653

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gnpx-20200630.xml EX-101.INS 452377
6 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20200630.xsd EX-101.SCH 35883
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gnpx-20200630_cal.xml EX-101.CAL 20126
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20200630_def.xml EX-101.DEF 264190
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20200630_lab.xml EX-101.LAB 247772
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20200630_pre.xml EX-101.PRE 279474
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38244 | Film No.: 201093231
SIC: 2834 Pharmaceutical Preparations